Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,564,902
+$9,320,797 QoQ
Shares Held
110,542
+462.2% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,606,617 across 416 Biotechnology names. CELC ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CELC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,564,902 | 110,542 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,244,105 | 19,661 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $13,807,506 | 138,435 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,102,953 | 22,327 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $200,409 | 15,012 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $160,384 | 15,864 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $203,091 | 15,515 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $127,315 | 8,539 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $125,257 | 7,647 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $138,779 | 6,425 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $77,832 | 5,342 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $39,128 | 4,281 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $71,732 | 6,533 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $902 | 88 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $630 | 45 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $692,919 | 69,016 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,042,395 | 114,549 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,541,282 | 271,795 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,863,535 | 217,099 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,618,252 | 201,014 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,680,768 | 70,032 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $688 | 48 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $302 | 33 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,946 | 508 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $7,308 | 1,055 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $97,506 | 15,001 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||